Roundtable on Black in cancer research and oncology - presented by Dr. Brandon Blue MD and Dr. Kilan Ashad-Bishop and Drs. Onyinye and Folu Balogun and Runcie C.W. Chidebe Dip., BSc., MSc., and Kathryn Mcginnis and Dr Paraskevi Mallini and Dr. Lisa Hoffmann-Haas

Roundtable on Black in cancer research and oncology

Brandon Blue, Kilan Ashad-Bishop, Onyinye and Folu Balogun and Runcie C.W. Chidebe

Dr. Brandon Blue MDDr. Kilan Ashad-BishopDrs. Onyinye and Folu BalogunRuncie C.W. Chidebe Dip., BSc., MSc.,
Slide at 18:29
Objectives The Onc Docs Dr. On. To describe the epidemiology of uterine cancer To characterize existing inequities in uterine cancer incidence, mortality and research To delineate the role of genomics in the treatment of uterine cancer Weill Cornell Medicine NewYork-Presbyterian
Share slide
Summary (AI generated)

So I just wanted to clarify that because you might see those terms used interchangeably. I also want to, of course, talk about the inequities when it comes to black individuals and endometrial cancer and discuss how genomics may help us tackle those inequities.

When we look at endometrial cancer, it is the most common gynecologic malignancy in the United States. Similarly, in most developed countries, it is also the most common.